BIO-RAD LABORATORIES overview

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/2872 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor...

Globavir Announces Licensing Agreement with Bio-Rad for Globavir's Dengue Detection Technology PR Newswire LOS ALTOS, Calif., Oct. 17, 2016 LOS ALTOS, Calif. , Oct. 17, 2016 /PRNewswire/ -- Globavir Biosciences, Inc., a biotechnology company that develops therapeutics for infectious diseases and oncology, and diagnostics for infectious diseases, announced a partnership with Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostics products. Under the terms...